The Effect of Spironolactone in Treatment of Essential Hypertensio
Phase 2
- Conditions
- Hypertension.Essential (primary) hypertension
- Registration Number
- IRCT201502011525N6
- Lead Sponsor
- Shiraz University of Midical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Inclusion crireria: systolic blood pressure more than 135 mmhg; diastolic blood pressure more than 85 mmhg
Exclusion criteria: serum creatinine more than 2 mg/dl; serum potassium more than 5 meq/l; renal or other endocrine diseases; diabetes
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Systolic blood pressure. Timepoint: Before intervention and 1 month after intervention. Method of measurement: Ambulatory 24 hour blood pressure holter monitoring.;Diastolic blood pressure. Timepoint: Before intervention and 1 month after intervention. Method of measurement: Ambulatory 24 hour blood pressure holter monitoring.
- Secondary Outcome Measures
Name Time Method evel of serum potassium. Timepoint: Before Intervention and One Month After Intervention. Method of measurement: Biochemical Measurements on Blood Sample.